Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Orin Hirschman IPWR Ideal Power Inc. 13G 9.5% 2y
Orin Hirschman IDN Intellicheck, Inc. 13G 8.2% 2y
Zeng Lingzhi UCAR U Power Ltd 13G 12.19% 2y
Xiangmin Cui CGON CG Oncology, Inc. 13G/A 8.2% 2y
Oxford Science Enterprises plc PEPG PepGen Inc. 13G 14.7% 2y
Southpoint Capital Advisors LP TNGX Tango Therapeutics, Inc. 13G/A 4.9% 2y
GK Investor LLC GNK Genco Shipping & Trading Ltd 13D/A 5.4% 2y
Wildcat Capital Management, LLC ULCC Frontier Group Holdings, Inc. 13G 12.6% 2y
EquityLine Alternate Assets GP Inc. MBAI MBody AI Ltd. 13D/A 13% 2y
John D. Gottwald TG Tredegar Corp 13D/A 20.7% 2y
Madryn Asset Management, LP GBNH Greenbrook TMS Inc. Common Shares 13D/A 63.4% 2y
Oaktree Capital Holdings, LLC TRMD TORM plc 13D/A 54.86% 2y
GREYBROOK HEALTH INC. GBNH Greenbrook TMS Inc. Common Shares 13D/A 54.4% 2y
Schlumberger N.V. (Schlumberger Limited) KITT Nauticus Robotics, Inc. 13D/A 17.4% 2y
Cloud Alliance Inc QH QUHUO Ltd 13D 25.96% 2y
HESTIA CAPITAL PARTNERS LP PBI Pitney Bowes Inc 13D/A 8.9% 2y
Schlumberger N.V. (Schlumberger Limited) KITT Nauticus Robotics, Inc. 13G 17.4% 2y
EIG Veteran Equity Aggregator, L.P. USAC USA Compression Partners, LP 13D/A 11% 2y
OSN Streaming Limited ANGH Anghami Inc 13D 62.9% 2y
Albion River Management LLC DCO Ducommun Inc 13D 9% 2y
GREAT POINT PARTNERS LLC OTLK Outlook Therapeutics, Inc. 13G 9.99% 2y
Nikolay Savchuk TRAW Traws Pharma, Inc. 13D 11.6% 2y
ECP ControlCo, LLC SHEN Shenandoah Telecommunications Co 13D 9.95% 2y
Philip Fayer NVEI Nuvei Corporation Subordinate Voting Shares 13D 21.8% 2y
Spartan Energy Partners LP KGS Kodiak Gas Services, Inc. 13D 6.2% 2y
FEDERATED HERMES, INC. FUSN Fusion Pharmaceuticals Inc. Common Shares 13G/A 0.11% 2y
Daniel Lau TSAT Telesat Corp 13G/A 6.6% 2y
I-B Good Works 4, LLC IBAC IB Acquisition Corp. 13D 18.5% 2y
Paradigm Biocapital Advisors LP YMAB Y-mAbs Therapeutics, Inc. Common Stock 13G 5.02% 2y
TEACHER RETIREMENT SYSTEM OF TEXAS AUNA Auna S.A. 13G 5.3% 2y
EcoR1 Capital, LLC LENZ LENZ Therapeutics, Inc. 13G/A 4.8% 2y
Casdin Capital, LLC IPSC Century Therapeutics, Inc. 13D/A 4.95% 2y
Yakira Capital Management, Inc. IRRX Integrated Rail and Resources Acquisition Corp. 13G/A 0% 2y
Vishal Garg BETR Better Home & Finance Holding Co 13D/A 19.7% 2y
MITCHELL SACKS TACT Transact Technologies Inc 13G 5.3% 2y
COLUMN GROUP L P NGM NGM Biopharmaceuticals, Inc. Common Stock 13D/A 100% 2y
The Sire Group Ltd. TTNP TITAN PHARMACEUTICAL INC 13D/A 14.1% 2y
SIT INVESTMENT ASSOCIATES INC NQP NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND 13G 5.41% 2y
SIT INVESTMENT ASSOCIATES INC NBB Nuveen Taxable Municipal Income Fund 13G 10.28% 2y
SIT INVESTMENT ASSOCIATES INC NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND 13G 5.21% 2y
SIT INVESTMENT ASSOCIATES INC NPCT Nuveen Core Plus Impact Fund 13G 5.17% 2y
Point72 Asset Management, L.P. STRO Sutro Biopharma, Inc. 13G 7.9% 2y
James B. Tananbaum KNTE Kinnate Biopharma Inc. Common Stock 13D/A 0% 2y
Adage Capital Management, L.P. ORKA Oruka Therapeutics, Inc. 13D 8.28% 2y
Chia-Lin Simmons LGMK LogicMark, Inc. 13D 6% 2y
Theodore Walker Cheng-De King OSG Octave Specialty Group Inc 13G 6.26% 2y
Weilai Zhang AEHL Antelope Enterprise Holdings Ltd 13D 85.77% 2y
BlackRock Inc. TBI TrueBlue, Inc. 13G/A 8.4% 2y
BlackRock Inc. CVI Cvr Energy Inc 13G/A 4.8% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 0% 2y